MRD - Head of Diagnostics, Top 15 Pharma
As part of an interview campaign to understand how minimal residual disease (MRD) testing and ctDNA monitoring are currently integrated into solid tumor care, we interviewed a diagnostics executive at a top pharma company.
February 8, 2023
Transcripts
$ 700.00 USD
February 8, 2023
Transcripts
$ 700.00 USD
February 8, 2023
Transcripts
$ 700.00 USD
No items found.
A diagnostics executive at a top pharma company discusses their current explorations of MRD and ctDNA monitoring assays. They are most familiar with Natera and Guardant as vendors, and in the future, they expect tumor-agnostic testing will be favored for broader use. They also provided feedback on ArcherDx, C2I and Grail. While they see utility of these technologies most in CRC and lung cancers, they imagine that there is potential for use in other indications such as breast, prostate, and ovarian cancers. This stakeholder mentioned these technologies already support registrational cancer trials for both targeted and immuno-oncology therapies. They believe that clinician education will be key hurdle needed to drive adoption.
Purchase Options
PDF deck with summarized feedback from stakeholders
Individual PDFs of call transcripts with stakeholders
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
PDF deck with summarized feedback from stakeholders
Individual PDFs of call transcripts with stakeholders
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
$ 700.00 USD
To claim your free report, simply fill out the form below with your contact information, and we’ll send it to you right away. Don’t miss out on this opportunity to gain a competitive edge in your industry. Sign up now!
Request AccessPDF deck with summarized feedback from stakeholders
Individual PDFs of call transcripts with stakeholders
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
$ 700.00 USD
$ 700.00 USD
PDF deck with summarized feedback from stakeholders
Individual PDFs of call transcripts with stakeholders
This package includes both the PDF deck and transcripts, providing a comprehensive understanding of stakeholders' views. You will receive a summarized report in the form of a PDF deck, as well as the full transcript of the discussions.
$ 700.00 USD
Experience the DeciBio Difference
Engage with our experts at DeciBio to discover how our tailored solutions can meet your unique needs.
Experience the DeciBio Difference
Engage with our experts at DeciBio to discover how our tailored solutions can meet your unique needs.
